共 8 条
- [1] RETRACTION: Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease (Retraction of Vol 49, Pg 971, 2018) [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2022, 56 (02) : 235 - 235
- [2] RETRACTED: Lentiviral Vector-Mediated SHC3 Silencing Exacerbates Oxidative Stress Injury in Nigral Dopamine Neurons by Regulating the PI3K-AKT-FoxO Signaling Pathway in Rats with Parkinson's Disease (Publication with Expression of Concern. See vol. 55, pg. 678, 2021) (Retracted Article) [J]. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 49 (03) : 971 - 984
- [3] Lentivirus vector mediated SOD1 gene silencing targets the PI3K/AKT signaling pathway to protect dopaminergic neurons from oxidative stress in the substantia nigra of Parkinson's disease rats [J]. INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2019, 12 (09): : 11210 - 11220
- [4] RETRACTION: Downregulated expression of microRNA-329 inhibits apoptosis of nigral dopaminergic neurons by regulating CDKN2D expression via the FoxO3a signaling pathway in rats with Parkinson's disease (Retraction of Vol 233, Pg 8617, 2018) [J]. JOURNAL OF CELLULAR PHYSIOLOGY, 2022, 237 (03) : 1997 - 1997
- [5] Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway (Publication with Expression of Concern. See vol. 114, 2023) [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2019, 75
- [6] Downregulation of lncRNA UCA1 ameliorates the damage of dopaminergic neurons, reduces oxidative stress and inflammation in Parkinson's disease through the inhibition of the PI3K/Akt signaling pathway (Expression of Concern of Vol 75, 10.1016/J.INTIMP.2019.105734, 2019) [J]. INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 114
- [8] RETRACTED: Long noncodinq RNA HAGLROS regulates apoptosis and autophagy in Parkinson's disease via regulating miR-100/ATG10 axis and PI3K/Akt/mTOR pathway activation (Publication with Expression of Concern. See vol. 48, pg. 708, 2020) (Retracted article. See vol. 49, pg. 543, 2021) [J]. ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2019, 47 (01) : 2764 - 2774